Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
national blog main
national top stories
san francisco blog main
san francisco top stories
texas blog main
6
×
texas top stories
6
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
cancer
amgen
clinical trials
deals
gene therapy
medicare
merck
novartis
pfizer
spark therapeutics
alnylam pharmaceuticals
amicus therapeutics
biogen
What
patients
6
×
bio
drug
roundup
cancer
fda
gene
market
medicine
moves
therapy
acquisitions
advantages
albert
allison
aren’t
bar
becker
biggest
billions
bourla
brings
cancers
ceo
company
countless
crispr
developers
dollars
drugs
eaton
eisai
expect
fight
flags
future
gamble
harnessing
healthcare
help
Language
unset
unknown
Current search:
patients
×
" texas top stories "
×
" texas blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More